Abstract | BACKGROUND: MATERIALS AND METHODS: A randomized, prospective single institutional case control study was performed between April 2012 and November 2012 comparing the influence of oral glutamine on radiation induced mucositis in head and neck malignancy patients. Seventy biopsy proven patients with head and neck cancer receiving primary or adjuvant radiation therapy were randomized to receive either oral glutamine suspension daily 2h before radiation in the study arm (10 g in 1000 ml of water) (n = 35) or nothing before radiation; control arm (n = 35). RESULTS AND ANALYSIS: Total 32 patients (91.43%) in the glutamine arm and total 34 patients (97.15%) developed mucositis. Grade 3 mucositis (14.29%) and grade 4 mucositis (2.86%) in the study arm (who received oral glutamine) were significantly less (P = 0.02 and P = 0.04, respectively) in the glutamine arm. The mean duration of grade 3 or worse mucositis (grade 3 and grade 4) was significantly less (6.6 days vs. 9.2 days) in study arm with P < 0.001. Mean time of onset of mucositis was significantly delayed in patients who took glutamine in comparison to control arm with P < 0.001. CONCLUSION:
|
Authors | Subrata Chattopadhyay, Aramita Saha, Mohammad Azam, Anindya Mukherjee, Prabir Kumar Sur |
Journal | South Asian journal of cancer
(South Asian J Cancer)
Vol. 3
Issue 1
Pg. 8-12
(Jan 2014)
ISSN: 2278-330X [Print] India |
PMID | 24665438
(Publication Type: Journal Article)
|